Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Depoxythilone - Beijing Biostar Technologies

Drug Profile

Depoxythilone - Beijing Biostar Technologies

Alternative Names: UTD-1; Utidelone - Beijing Biostar Technologies

Latest Information Update: 20 Sep 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Beijing Biostar Technologies
  • Class Antineoplastics; Epothilones
  • Mechanism of Action Mitosis inhibitors; Tubulin polymerisation promoters
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase III Breast cancer
  • Phase II Colorectal cancer; Non-small cell lung cancer

Most Recent Events

  • 08 Apr 2019 Beijing Biostar Technologies plans a phase II trial for Colorectal cancer (Unresectable/Inoperable, Late-stage disease, Metastatic disease, Second-line therapy or greater) in China in April 2019 (NCT03906565)
  • 01 Apr 2019 Phase-II clinical trials in Colorectal cancer (Late-stage disease, Metastatic disease, Inoperable/Unresectable, Second-line therapy or greater) in China (IV) (NCT03906565)
  • 04 Mar 2019 Phase-II clinical trials in Non-small cell lung cancer (Monotherapy, Late-stage disease, Metastatic disease, Second-line therapy or greater) in China (IV, Injection) (NCT03693547)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top